Enalaprilat, sold under the brand name Vasotec among others, is a medication used to treat high blood pressure, diabetic kidney disease, and heart failure. For heart failure, it is generally used with a diuretic, such as furosemide.It is given by injection into a vein.Onset of effects are typically within an hour when taken by mouth and last for up to a day.

Market Analysis and Insights: Global Enalaprilat Market
The global Enalaprilat market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Enalaprilat Scope and Market Size
The global Enalaprilat market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enalaprilat market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
1mL Vial
2mL Vial

Segment by Application
Hospital
Pharmacy

The Enalaprilat market is analysed and market size information is provided by regions (countries). Segment by Application, the Enalaprilat market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Hikma Pharmaceuticals
Teva(Barr Pharmaceuticals)
Novartis(Hexal AG)
SteriMax
KRKA
Cadila Pharmaceuticals
Balkan Pharmaceuticals